Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism.

Shinall MC Jr, Dahir KM, Broome JT.

Endocr Pract. 2013 Jul-Aug;19(4):697-702. doi: 10.4158/EP12284.RA. Review.

PMID:
23425644
2.

Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.

Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Brixen K, Mosekilde L.

Clin Endocrinol (Oxf). 2008 Nov;69(5):713-20. doi: 10.1111/j.1365-2265.2008.03259.x. Epub 2008 Apr 10.

PMID:
18410554
3.

Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.

Stratta P, Merlotti G, Musetti C, Quaglia M, Pagani A, Izzo C, Radin E, Airoldi A, Baorda F, Palladino T, Leone MP, Guarnieri V.

Nephrol Dial Transplant. 2014 Oct;29(10):1902-9. doi: 10.1093/ndt/gfu065. Epub 2014 Aug 7.

PMID:
25104082
4.

Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.

Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen K, Mosekilde L.

Eur J Endocrinol. 2008 Dec;159(6):719-27. doi: 10.1530/EJE-08-0440. Epub 2008 Sep 11.

5.

Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.

Vargas-Poussou R, Mansour-Hendili L, Baron S, Bertocchio JP, Travers C, Simian C, Treard C, Baudouin V, Beltran S, Broux F, Camard O, Cloarec S, Cormier C, Debussche X, Dubosclard E, Eid C, Haymann JP, Kiando SR, Kuhn JM, Lefort G, Linglart A, Lucas-Pouliquen B, Macher MA, Maruani G, Ouzounian S, Polak M, Requeda E, Robier D, Silve C, Souberbielle JC, Tack I, Vezzosi D, Jeunemaitre X, Houillier P.

J Clin Endocrinol Metab. 2016 May;101(5):2185-95. doi: 10.1210/jc.2015-3442. Epub 2016 Mar 10.

PMID:
26963950
6.

Low urine calcium excretion in African American patients with primary hyperparathyroidism.

Taha W, Singh N, Flack JM, Abou-Samra AB.

Endocr Pract. 2011 Nov-Dec;17(6):867-72. doi: 10.4158/EP11022.OR.

PMID:
21613053
7.

Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.

Eldeiry LS, Ruan DT, Brown EM, Gaglia JL, Garber JR.

Endocr Pract. 2012 May-Jun;18(3):412-7. doi: 10.4158/EP11272.RA. Review.

PMID:
22232026
8.

Familial hypocalciuric hypercalcaemia: a review.

Christensen SE, Nissen PH, Vestergaard P, Mosekilde L.

Curr Opin Endocrinol Diabetes Obes. 2011 Dec;18(6):359-70. doi: 10.1097/MED.0b013e32834c3c7c. Review.

PMID:
21986511
9.

[Usefulness of genetic tests in familial hypocalciuric hypercalcemia with atypical clinical presentation].

Fernández López I, Fernández Peña I, Cózar León MV, Viloria Peñas MM, Martínez De Pinillos Gordillo G, Fernández-Ladreda MT, Duran García S.

Endocrinol Nutr. 2011 Aug-Sep;58(7):325-30. doi: 10.1016/j.endonu.2011.04.004. Epub 2011 Jun 21. Spanish.

PMID:
21697018
10.

Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study.

Isaksen T, Nielsen CS, Christensen SE, Nissen PH, Heickendorff L, Mosekilde L.

Calcif Tissue Int. 2011 Oct;89(4):285-94. doi: 10.1007/s00223-011-9517-x. Epub 2011 Jul 22.

PMID:
21785908
11.

Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism.

Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen K, Mosekilde L.

Clin Endocrinol (Oxf). 2009 Dec;71(6):798-807. doi: 10.1111/j.1365-2265.2009.03557.x. Epub 2009 Feb 25.

PMID:
19250271
12.

Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.

Guarnieri V, Canaff L, Yun FH, Scillitani A, Battista C, Muscarella LA, Wong BY, Notarangelo A, D'Agruma L, Sacco M, Cole DE, Hendy GN.

J Clin Endocrinol Metab. 2010 Apr;95(4):1819-29. doi: 10.1210/jc.2008-2430. Epub 2010 Feb 17.

PMID:
20164288
14.

The pathophysiology of primary hyperparathyroidism.

Brown EM.

J Bone Miner Res. 2002 Nov;17 Suppl 2:N24-9. Review.

PMID:
12412774
15.

Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor.

Grant MP, Stepanchick A, Breitwieser GE.

Mol Endocrinol. 2012 Dec;26(12):2081-91. doi: 10.1210/me.2012-1232. Epub 2012 Oct 17.

16.

A novel mutation of the calcium-sensing receptor gene in a German subject with familial hypocalciuric hypercalcemia and primary hyperparathyroidism.

Papadakis M, Meurer N, Margariti T, Meyer A, Weyerbrock N, Dotzenrath C.

Hormones (Athens). 2016 Oct;15(4):557-559. doi: 10.14310/horm.2002.1711.

17.

Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism.

Frank-Raue K, Leidig-Bruckner G, Haag C, Schulze E, Lorenz A, Schmitz-Winnenthal H, Raue F.

Clin Endocrinol (Oxf). 2011 Jul;75(1):50-5. doi: 10.1111/j.1365-2265.2011.04059.x.

PMID:
21521328
18.

Familial hypocalciuric hypercalcemia and calcium sensing receptor.

Mrgan M, Nielsen S, Brixen K.

Acta Clin Croat. 2014 Jun;53(2):220-5. Review.

PMID:
25163238
19.

A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria.

Mastromatteo E, Lamacchia O, Campo MR, Conserva A, Baorda F, Cinque L, Guarnieri V, Scillitani A, Cignarelli M.

BMC Endocr Disord. 2014 Oct 7;14:81. doi: 10.1186/1472-6823-14-81.

20.

Familial hypocalciuric hypercalcemia associated with crystal deposition disease.

Alix L, Guggenbuhl P.

Joint Bone Spine. 2015 Jan;82(1):60-2. doi: 10.1016/j.jbspin.2014.08.007. Epub 2014 Oct 13.

PMID:
25444087

Supplemental Content

Support Center